Treatment of vasculoproliferative conditions

Details for Australian Patent Application No. 2010290986 (hide)

Owner UCL Business PLC

Inventors Greenwood, John; Moss, Stephen; Wang, Xiaomeng

Agent Spruson & Ferguson

Pub. Number AU-A-2010290986

PCT Pub. Number WO2011/027129

Priority 0915515.1 04.09.09 GB

Filing date 6 September 2010

Wipo publication date 10 March 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/027129 Priority application(s): WO2011/027129

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010290989-CLEC14A inhibitors

2010290985-Use of non-digestible oligosaccharides